List of Chapters/Sections(Table Of Content)
1 Tourette Syndrome Drug Market Overview
1.1 Product Overview and Scope of Tourette Syndrome Drug
1.2 Tourette Syndrome Drug Segment by Type
1.2.1 Global Tourette Syndrome Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 AZD-5213
1.2.3 CPP-115
1.2.4 Dutetrabenazine ER
1.2.5 Ecopipam Hydrochloride
1.2.6 Others
1.3 Tourette Syndrome Drug Segment by Application
1.3.1 Global Tourette Syndrome Drug Sales Comparison by Application: (2022-2028)
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Global Tourette Syndrome Drug Market Size Estimates and Forecasts
1.4.1 Global Tourette Syndrome Drug Revenue 2017-2028
1.4.2 Global Tourette Syndrome Drug Sales 2017-2028
1.4.3 Tourette Syndrome Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Tourette Syndrome Drug Market Competition by Manufacturers
2.1 Global Tourette Syndrome Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Tourette Syndrome Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Tourette Syndrome Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Tourette Syndrome Drug Manufacturing Sites, Area Served, Product Type
2.5 Tourette Syndrome Drug Market Competitive Situation and Trends
2.5.1 Tourette Syndrome Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Tourette Syndrome Drug Players Market Share by Revenue
2.5.3 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tourette Syndrome Drug Retrospective Market Scenario by Region
3.1 Global Tourette Syndrome Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Tourette Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Tourette Syndrome Drug Market Facts & Figures by Country
3.3.1 North America Tourette Syndrome Drug Sales by Country
3.3.2 North America Tourette Syndrome Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Tourette Syndrome Drug Market Facts & Figures by Country
3.4.1 Europe Tourette Syndrome Drug Sales by Country
3.4.2 Europe Tourette Syndrome Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Tourette Syndrome Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Tourette Syndrome Drug Sales by Region
3.5.2 Asia Pacific Tourette Syndrome Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Tourette Syndrome Drug Market Facts & Figures by Country
3.6.1 Latin America Tourette Syndrome Drug Sales by Country
3.6.2 Latin America Tourette Syndrome Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Tourette Syndrome Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Tourette Syndrome Drug Sales by Country
3.7.2 Middle East and Africa Tourette Syndrome Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Tourette Syndrome Drug Historic Market Analysis by Type
4.1 Global Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
4.2 Global Tourette Syndrome Drug Revenue Market Share by Type (2017-2022)
4.3 Global Tourette Syndrome Drug Price by Type (2017-2022)
5 Global Tourette Syndrome Drug Historic Market Analysis by Application
5.1 Global Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
5.2 Global Tourette Syndrome Drug Revenue Market Share by Application (2017-2022)
5.3 Global Tourette Syndrome Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Abide Therapeutics Inc
6.1.1 Abide Therapeutics Inc Corporation Information
6.1.2 Abide Therapeutics Inc Description and Business Overview
6.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Product Portfolio
6.1.5 Abide Therapeutics Inc Recent Developments/Updates
6.2 Catalyst Pharmaceuticals Inc
6.2.1 Catalyst Pharmaceuticals Inc Corporation Information
6.2.2 Catalyst Pharmaceuticals Inc Description and Business Overview
6.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
6.2.5 Catalyst Pharmaceuticals Inc Recent Developments/Updates
6.3 Neurocrine Biosciences Inc
6.3.1 Neurocrine Biosciences Inc Corporation Information
6.3.2 Neurocrine Biosciences Inc Description and Business Overview
6.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Product Portfolio
6.3.5 Neurocrine Biosciences Inc Recent Developments/Updates
6.4 Psyadon Pharmaceuticals Inc
6.4.1 Psyadon Pharmaceuticals Inc Corporation Information
6.4.2 Psyadon Pharmaceuticals Inc Description and Business Overview
6.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
6.4.5 Psyadon Pharmaceuticals Inc Recent Developments/Updates
6.5 Reviva Pharmaceuticals Inc
6.5.1 Reviva Pharmaceuticals Inc Corporation Information
6.5.2 Reviva Pharmaceuticals Inc Description and Business Overview
6.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
6.5.5 Reviva Pharmaceuticals Inc Recent Developments/Updates
6.6 Synchroneuron Inc
6.6.1 Synchroneuron Inc Corporation Information
6.6.2 Synchroneuron Inc Description and Business Overview
6.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Synchroneuron Inc Tourette Syndrome Drug Product Portfolio
6.6.5 Synchroneuron Inc Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Ltd
6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Portfolio
6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.8 Therapix Biosciences Ltd
6.8.1 Therapix Biosciences Ltd Corporation Information
6.8.2 Therapix Biosciences Ltd Description and Business Overview
6.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Product Portfolio
6.8.5 Therapix Biosciences Ltd Recent Developments/Updates
7 Tourette Syndrome Drug Manufacturing Cost Analysis
7.1 Tourette Syndrome Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Tourette Syndrome Drug
7.4 Tourette Syndrome Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Tourette Syndrome Drug Distributors List
8.3 Tourette Syndrome Drug Customers
9 Tourette Syndrome Drug Market Dynamics
9.1 Tourette Syndrome Drug Industry Trends
9.2 Tourette Syndrome Drug Market Drivers
9.3 Tourette Syndrome Drug Market Challenges
9.4 Tourette Syndrome Drug Market Restraints
10 Global Market Forecast
10.1 Tourette Syndrome Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Tourette Syndrome Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Tourette Syndrome Drug by Type (2023-2028)
10.2 Tourette Syndrome Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Tourette Syndrome Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Tourette Syndrome Drug by Application (2023-2028)
10.3 Tourette Syndrome Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Tourette Syndrome Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Tourette Syndrome Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
